The marginal zone (MZ) of the spleen is an important site for the capture of blood-borne pathogens and a gateway for lymphocytes entering the white pulp. We have recently reported that Leishmania donovani infection results in a remarkably selective loss of MZ macrophages (MZM) from the MZ. To understand the basis of this observation, we have investigated how MZM maintain their anatomical distribution in the steady state in uninfected mice. We now report that plt/plt mice, which lack functional CCL19 and CCL21, have significantly reduced numbers of MZM compared with normal C57BL/6 (B6) mice. Similarly, in B6.CD45.13plt/plt chimeras, donor-derived MZM were rare compared with the number observed in reciprocal plt/plt3 B6.CD45.1 chimeras. 
T he marginal zone (MZ) 4 of the spleen is the boundary between the red pulp and the white pulp (1) . It is comprised of unique MZ B cells (2) , dendritic cells (3) , and two types of macrophages enmeshed within a reticular cell network (4, 5) . Marginal metallophilic macrophages (MMM) localize at the inner rim between the MZ and lymphocyte-rich white pulp, whereas MZ macrophages (MZM) are localized at the outer boundary of the MZ, adjacent to the red pulp. The MZ has various functions, including the capture of blood-borne pathogens (6) , the regulation of lymphocyte trafficking into the white pulp (7) , and the generation of Ag-specific B cell responses to T cell-independent Ags (8) . Specifically, MZM are important for clearance of Leishmania donovani (9) , lymphocytic choriomeningitis virus (10) , and Listeria monocytogenesis (11) . In some, but not all, cases, mice lacking MZM have been shown to be significantly more susceptible to infection and have altered T cell immune responses (11, 12) .
Several studies using gene-targeted mice have shown that the development of the MZ is regulated through complex signaling pathways involving TNF superfamily members and transcription factors, such as those of the NF-B family (reviewed in Ref. 13 ). Thus, lymphotoxin-␣ (LT-␣)-, NF-B-inducing kinase-, or RelBdeficient mice completely lack a MZ (14 -16), whereas NF-B2-deficient mice have no MMM, but retain almost normal levels of MZM (17) . Many of the cytokines and transcriptional factors regulating splenic architecture function by regulating chemokine expression (18, 19) . Specific blockage of TNF superfamily members in normal adult mice has also demonstrated that these cytokines may play a role in the maintenance of lymphoid structure (20) . Whether chemokines are essential for the steady state maintenance of MZM in their characteristic position in the MZ has not been determined, however.
We have recently been studying the dramatic remodeling of splenic microarchitecture that occurs as a result of chronic infection with L. donovani. Our studies indicate that two major structural changes occur: loss of MZM (21) and loss of gp38 ϩ stromal cells from the T cell zone (22) . Both events are mediated directly or indirectly by TNF. Given that gp38 ϩ stromal cells are a major source of both CCL19 and CCL21, these findings lead us to postulate that the distribution of MZM in the spleen of normal uninfected mice might be regulated by chemotactic responses to these chemokines.
Mice bearing the paucity of lymph node T cells ( plt) mutation (23) have a spontaneous recessive mutation in chromosome 4 that results in loss of both functional CCL19 and CCL21b genes (24) . In this study we report that 1) MZM are selectively deficient in the MZ of plt/plt mice; 2) treatment of normal mice with pertussis toxin (PTx) results in the migration of MZM out of the MZ; 3) MZM can migrate in response to CCL19 and CCL21 in vitro; and 4) MZM colocalize with CCL21-expressing endothelial cells in the MZ. Together these findings lead us to conclude that the distribution of MZM is regulated by CCL21 and, perhaps to a lesser extent, CCL19 and propose that loss or aberrant expression of chemokines may underpin the extensive remodeling of lymphoid tissue noted in leishmaniasis and other chronic infections.
Materials and Methods
Mice plt/plt mice backcrossed to the B6 background were provided by Drs. H. Hengartner and T. Junt (University of Zurich, Zurich, Switzerland). B6.CD45.1 mice were bred at the London School of Hygiene and Tropical Medicine under barrier conditions. B6 (CD45.2) mice were purchased from Charles River Laboratories (Margate, U.K.) and housed under specific pathogen-free conditions. Five hundred nanograms of PTx or PTx B oligomer (List Biological Laboratories, Campbell, CA) in saline was administrated by i.p. injection as indicated. For T cell depletion experiments, 500 and 250 g of anti-CD4 (YTS 191.1) and anti-CD8 (YTS 169.4) mAb or control rat IgG (MAC5) was administrated by i.p. injection at 4 days and 1 day before killing, respectively.
Immunohistochemistry
Immunohistochemistry was performed on 6-m frozen sections as described previously (9) . Primary Abs were purified or biotinylated HL3 (anti-mouse CD11c), II/41 (anti-IgM), and A20 (anti-CD45.1; BD Pharmingen, San Jose, CA); 3D6.112 (anti-CD169), CI:A3-1(anti-F4/80), MCEA-367 (anti-MAdCAM-1), 390 (anti-CD31), KAT-1 (anti-ICAM-1; CD54), and M/K-2 (anti-VCAM-1; CD106; Serotec, Oxford, U.K.); ER-TR7 (BMA Biomedicals, Augst, Switzerland); anti-mouse CCL21 (R&D Systems, Abingdon, U.K.); ER-TR9 (anti-specific ICAM-3-grabbing nonintegrin-related gene 1; SIGNR1; a gift from G. Kraal, Free University, Amsterdam, The Netherlands); and FITC-conjugated anti-mouse IgD (11-26c.2a: BD Pharmingen). Secondary Abs were biotinylated rabbit anti-rat IgG (Vector Laboratories, Petersborough, U.K.), biotinylated rabbit anti-rat Ig (for ER-TR9; DakoCytomation, Ely, U.K.), donkey anti-goat IgG (for CCL21; Jackson ImmunoResearch Laboratories, West Grove, PA), Alexa 488-conjugated goat anti-rat IgG, or Alexa 546-conjugated streptavidin (Molecular Probes, Leiden, The Netherlands). As appropriate, sections were developed with Vector Elite-ABC kit followed by Vector 3,3Ј-diaminobenzidine substrate kit (Vector Laboratories), or directly viewed using a Zeiss LSM510 confocal microscope. In some experiments mice were injected i.v. with 200 l of 5% (v/v, in 0.9% NaCl) India ink (Rowney and Company, Brackwell, U.K.) to identify MZM.
Flow cytometry
MZ B cells were enumerated by flow cytometry using RA3-6B2 (anti-CD45R/B220) and KMC8 (anti-CD9). To evaluate MZM, 100 g of FITCconjugated dextran (Molecular Probes) was administrated i.v. to B6 mice. After 45 min, spleens were harvested and digested in RPMI 1640 (Invitrogen Life Technologies, Paisley, U.K.) containing 0.1% collagenase D (Roche, Mannheim, Germany) and 100 g/ml DNase I (Sigma-Aldrich, Dorset, U.K.) at 37°C for 30 min. After washing with calcium-free medium, cells were resuspended with 2 ml of Ca-free PBS containing 5 mM EDTA and 1% FCS (Sigma-Aldrich) and were incubated with magnetic microbeads conjugated with anti-mouse CD19 (1D3) and anti-mouse Thy1.2 (30-H12; Miltenyi Biotec, Bergisch Gladbach, Germany), then B and T cells were negatively removed by magnetic sorting (Miltenyi Biotec). Cells were stained for flow cytometry to identify ER-TR9 ϩ FITC ϩ MZM or elucidate CCR7 expression with CCL19-Ig (a gift from Drs. T. Springer and U. von Andrian, Harvard Medical School, Boston, MA) (25) and were analyzed using FACSCalibur (BD Biosciences, Mountain View, CA).
Bone marrow (BM) transplantation
BM chimeric mice were prepared as previously described (26) . Briefly, recipient mice were irradiated twice (48 h apart) with 5.5 Gy, then engrafted with 10 7 donor-derived BM cells i.v. via the tail vein. After 4 wk, PBLs in chimeric mice were Ͼ98% donor derived (data not shown). Mice were injected i.v. with 200 l of 5% India ink 24 h before killing.
In vitro migration assay
Migration assays were conducted as previously described (22) with modification. Briefly, assays were performed in Transwell inserts (5-m pore size; Fisher Scientific, Longborough, U.K.) placed in 24-well plates containing 500 l of medium, CCL19, or CCL21 solution (R&D Systems). After 3-h incubation, cells in the lower wells were collected, and 10 4 10-m microsphere beads were added (Polysciences, Warrington, PA). Cells were stained for flow cytometry to identify ER-TR9 ϩ FITC ϩ MZM and were analyzed using FACSCalibur (BD Biosciences). The migration index is calculated as the number of MZM migrating in response to a chemokine divided by the number migrating in medium alone.
Results

MZM are selectively deficient in plt/plt mice
In mice chronically infected with L. donovani, we previously observed that the expression of CCL19 and CCL21 by stromal cells was dramatically reduced (22) and that MZM were selectively lost from their normal position at the outer edge of the MZ (21) . To determine whether these two events might be causally linked, we assessed the importance of CCL19 and CCL21 in the regulation of MZM positioning within the MZ of normal and chemokine-deficient ( plt/plt) mice (Fig. 1) . In normal B6 mice, a discrete population of ER-TR9 ϩ MZM capable of taking up injected India ink was clearly evident (Fig. 1A) . In contrast, MZM as defined by either ER-TR9 staining or India ink uptake were significantly reduced in number in plt/plt mice (Fig. 1B) . CD169
ϩ MMM, which localized at the inner rim of the MZ in B6 mice (Fig. 1C) , were also noted to be distributed in a broader band in plt/plt mice and extended into the white pulp (Fig. 1D) . The distribution of F4/80 ϩ red pulp macrophages was not significantly different when comparing B6 and plt/plt mice (Fig. 1, E and F) . plt/plt mice had no gross defects in the positioning of various endothelial populations, as defined by staining with CD54 and CD106 (data not shown). Furthermore, variation in T cell numbers in plt/plt mice compared with B6 mice was unlikely to be of importance, because depletion of T cells in B6 mice did not influence the number or localization of MZM (data not shown). To further quantify the loss of MZM in plt/plt mice we used two approaches. First, the number of MZM was directly counted in tissue sections, on the basis of India ink uptake (Fig. 1G) . Second, the frequency of MZM was determined in total spleen cell populations by staining with ER-TR9 (Fig. 1H ). Both approaches confirmed the deficiency of MZM in plt/plt mice compared with B6 mice.
Radioresistant cells in plt/plt mice are responsible for the deficiency of MZM
To exclude the possibility that the chromosomal deletion found in plt/plt mice disrupted genes essential for the development of MZM, we established reciprocal BM chimeras between B6.CD45.1 and plt/plt (CD45.2) mice. As anticipated (23), both plt/plt mice and B6.CD45.13plt/plt mice had poorly developed T cell areas compared with either plt/plt3 B6.CD45.1 or B63 B6.CD45.1 mice (data not shown). To unambiguously identify MZM as being of donor or recipient origin, we used a combination of India ink uptake and CD45.1 staining. The plt/ plt3 B6.CD45.1 and B63 B6.CD45.1 mice had almost normal numbers of MZM, as visualized by India ink uptake or ER-TR9 Ab ( Fig. 2A and data not shown) . Staining for CD45.1 identified a small number of residual recipient-derived cells in these chimeras, but ϳ90% of the cells that took up India ink were clearly negative for CD45.1 expression, indicating their donor origin (Fig. 2, C and  D) . However, the total number of MZM in B6.CD45.13plt/plt mice was significantly reduced (Fig. 2, B and E) to the level seen in plt/plt mice (c.f., Fig. 1, A and G) . In these BM chimeras, the distribution of MMM showed either narrow or broad distribution in keeping with the genotype of the recipient (Fig. 2, A and B) . Thus, the lack of MZM in plt/plt mice is not due to a defect in the capacity of plt/plt BM progenitors to develop into MZM.
plt/plt mice have normal levels of MZ B cells
Recently, it was reported that interactions between MZM and MZ B cells are necessary to maintain MZ structure (27) . To rule out the possibility that changes to MZ B cells in plt/plt mice might have occurred with reciprocal effects on MZM distribution, we stained splenocytes from plt/plt and B6 mice with B220 and CD9 (Fig.  3A) , a new marker of MZ B cells that is not expressed on spleen follicular B cells (28) . No significant difference was seen in either the proportion (Fig. 3B) or total number (Fig. 3C) of MZ B cells in these mice. Furthermore, the distribution of MZ B cells (identified by IgM and IgD staining) in the spleen of B6 and plt/plt mice was identical (Fig. 2D) . This result is consistent with data from a recent study that indicated MZ B cell numbers and distribution are normal in CCR7/CXCR5 double-deficient mice (29) . Taken together, our data suggest that the absence of MZM from the spleen in plt/plt mice is not attributable to defective interaction between MZM and MZ B cells, but, rather, is a direct consequence of the lack of CCL19 and/or CCL21.
PTx treatment induces redistribution of MZM
To formally demonstrate that active chemokine secretion is responsible for maintenance of MZM in their distinctive position within the MZ, we blocked chemokine receptor signaling in vivo by the administration of PTx, an inhibitor of GTP-binding proteins including chemokine receptors (30) . After 3 days of PTx treatment, India ink-positive MZM had begun to exit the MZ and were found within the red pulp (Fig. 4) . India ink-positive cells were confirmed as MZM by ER-TR9 staining, a result that also served to demonstrate that India ink had not been released after PTx treatment and then phagocytosed by red pulp macrophages (data not FIGURE 2. MZM can be derived from plt/plt bone marrow precursors. India ink was injected the day before mice were killed. Six-micron frozen sections were cut from the spleens from plt/plt3 B6.CD45.1 (A) or B6.CD45.13plt/plt (B) mice. India ink and CD169 were used for MZM and MMM, respectively. Original magnification, ϫ100. C and D, CD45.1 staining was performed on spleen sections from plt/plt3 B6.CD45.1 (C) or B63 B6.CD45.1 (D) mice. Original magnification, ϫ400. E, The number of India ink-positive MZM was determined from ϳ10 fields/mouse (n ϭ 4 mice) in B6 vs plt/plt mice. ‫,ء‬ p Ͻ 0.05. n.s., not significant.
shown). After 6 days of PTx treatment, MZM were rarely seen in the MZ, but some could still be observed throughout the red pulp. In contrast, mice treated with PTx B oligomer did not alter the distribution of MZM (Fig. 4) . The distribution of F4/80 ϩ red pulp macrophages was not significantly altered, except for some compression due to the increased granulocyte numbers also associated with PTx treatment (data not shown). These results strongly support that idea that continuous chemokine signaling is necessary for the maintenance of position of MZM in the murine spleen.
MZM migrate in response to CCL19 and CCL21
The studies described above using mutant mice and an in vivo antagonist of chemokine receptor signaling all suggest that MZM are responsive to the chemotactic activity of CCL19 and/or CCL21. To directly confirm whether MZM can indeed migrate in response to these specific chemokines, we enriched these cells and performed in vitro migration assays. To aid identification of MZM in vitro, we injected mice with FITC-dextran, a ligand for mSIGNR1 expressed on MZM (31, 32) . MZ B cells, which may also bind FITC dextran (32) , were removed by magnetic sorting from spleen cell suspensions before assay. Within the resultant spleen cell populations, FITC ϩ CD11c Ϫ B220 Ϫ cells were homogeneously positive for ER-TR9, and we regarded them as MZM (Fig. 5A) . Staining with a CCL19-Ig fusion protein (25) indicated that these cells weakly expressed CCR7, at a level below that seen on naive T cells or CD11c high dendritic cells (Fig. 5B) . In vitro, CCL21 stimulated migration of MZM in a dose-dependent fashion, with an optimal response at 100 nM. Similarly, migration was observed to CCL19, with an optimal response at 200 nM. The absolute level of migration to CCL19 at the doses tested was nevertheless consistently lower than that seen with CCL21 (Fig. 5C) . Thus, we have demonstrated for the first time that MZM have the capacity to respond directly to these two constitutively expressed chemokines.
Expression of CCL21 on CD31 ϩ endothelial cells, but not MAdCAM-1 ϩ marginal sinus lining cells
The data shown above demonstrate that CCL21 can attract MZM in vitro. To evaluate whether in vivo expression of CCL21 is associated with distribution of MZM in the MZ, we stained spleen sections for CCL21 and stromal cell markers. As previously reported, CCL21 was mainly expressed by stromal cells in the T cell area of the spleen (19) as well as in the MZ area (Fig. 6 ). The specificity of CCL21 staining was confirmed by the lack of staining of spleen sections from plt/plt mice. No significant difference in the distribution of stromal cell markers MAdCAM-1, CD31, and ER-TR7 were observed between B6 and plt/plt mice (Fig. 6 , B, D, and F). Double staining with CCL21 and MAdCAM-1 showed that CCL21 expression in the MZ was not associated with the MAd-CAM-1 ϩ marginal sinus, but, rather, with cells in the outer perimeter of the MZ (Fig. 6A) . In contrast, CCL21 was found coexpressed on CD31 ϩ endothelial cells in the outer MZ (Fig. 6C ) and occasionally on ER-TR7 ϩ stromal cells (Fig. 6E) . In contrast, CCL19 expression, although readily observed in the periarteriolar T cell regions of the white pulp, was not detectable on cells within the MZ (22) (data not shown). Given the expression of CCL21 in the outer MZ, we lastly examined the distribution of MZM in relation to the position of CCL21 ϩ cells. India ink-positive MZM were found in many instances to be in close proximity to CD31 ϩ CCL21 ϩ endothelial cells (Fig. 6G ) Hence, these data indicate that MZM are positioned in the outer MZ coincident with expression of CCL21. 
Discussion
The precise development of lymphoid tissue architecture plays an important role during ontology in establishing an appropriate environment for the efficient generation of immune responses and is tightly regulated by stimuli acting through TNF superfamily receptors (33) . Notably, LT␣ 1 ␤ 2 -LT␤R interactions play an important role in orchestrating splenic architecture, including organization of the MZ and B cell follicles (14) . Recently, a role for B cells in the development and maintenance of the MZ has been described (34) . However, there have been few reports on the nature of the factor(s) responsible for directing and maintaining the positioning of discrete macrophage populations in the various spleen compartments. To our knowledge, this is the first report demonstrating that continuous chemokine signaling, in particular CCL21, is necessary for the localization of MZM at their unique position within the MZ.
A number of observations have lead to the conclusion that CCL21 and CCL19 play an important role in the localization of MZM to the MZ; MZM express CCR7 and migrate in response to CCL21 and CCL19 in vitro, MZM distribution in normal mice is reflected in the distribution of CCL21 ϩ CD31 ϩ endothelial cells in the outer MZ, and pharmacologic and genetic disruption of CCL21/CCL19 function interferes with MZM positioning. Furthermore, the absence of detectable CCL19 expression in the MZ suggests that CCL21 may play the most dominant role in MZM localization in vivo. Although our data clearly implicate these chemokines in MZM positioning, the retention of a few MZM in the MZ of plt/plt mice suggests that there may be some redundancy in the signals required. In addition, the common involvement of CCL19/CCL21 in the migration of MZM, T cells (35) , and dendritic cells (36) raises several new questions concerning the anatomical segregation of these cells that occurs in the resting spleen. MZM express low levels of CCR7 and respond more weakly than either T cells or dendritic cells in in vitro migration assays. Hence, MZM migration into the periarteriolar region, where stromal cells express abundant CCL21 and CCL19 (22) , may be more readily opposed by other chemokines and be more readily affected by altered levels of chemokine expression. Indeed, in our studies of dendritic cell migration, we clearly demonstrated that even the minimal level of CCL21 expressed on the endothelium of the central arterioles in L. donovani-infected mice was sufficient to recruit CCR7 ϩ CD11c high dendritic cells from the MZ into the periarteriolar region (22) . It is also possible that MZM positioning is influenced by the coordinate action of multiple other chemokines acting with CCL19 and/or CCL21, as, for example, in the case of CXCL12 (37) . The MAdCAM-1 ϩ endothelium of the marginal sinus has been suggested to have a role in retention of MMM in the MZ (38) , but no differences in architecture of the marginal sinus were observed in plt/plt mice, suggesting that the structural elements of the MZ were indeed intact in these chemokine-deficient mice. However, CCL21 expression was observed on both the endothelial cells of the central arterioles as well as on CD31 ϩ endothelial cells in the MZ of B6 mice, whereas it was absent in plt/plt mice. The observation that MZM are in close proximity to these CCL21 ϩ CD31 ϩ cells would also be compatible with a model in which MZM additionally engage in stronger adhesive interactions with stromal elements found in MZ compared with T cells and dendritic cells. Additional studies are required to distinguish between these possibilities.
The results of this study now also suggest an explanation for our previous finding that MZM are lost from the spleen of mice with chronic L. donovani infection. We previously demonstrated that loss of MZM was a result of excess TNF production, in that it was less evident in TNF-deficient mice (21) . Excess TNF was also associated with a striking loss of T zone stromal cells, an important source of CCL19 and CCL21 in the spleen. Hence, the expression of CCL19 and CCL21, as determined by immunohistochemistry, is greatly reduced in infected mice (22) . Our new data suggest that these events are causally related, and that TNF-mediated loss of chemokine production is the mechanism underlying the emigration of MZM from the MZ during infection.
In conclusion, this study indicates that the localization of MZM is largely regulated through signals delivered by CCL21 and perhaps, to a lesser extent, CCL19, providing a novel mechanism for the loss of organization of macrophages as seen in murine leishmaniasis. The importance of these or other chemokines for the maintenance of macrophage positioning in human disease remains to be determined.
